These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20442377)

  • 1. Aggressive lipid, hypertension targeting yields no benefit for some with diabetes.
    Mitka M
    JAMA; 2010 May; 303(17):1681-3. PubMed ID: 20442377
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preventive cardiovascular recommendations].
    Maiques Galán A; Villar Alvarez F; Brotons Cuixart C; Torcal Laguna J; Orozco-Beltrán D; Navarro Pérez J; Lobos-Bejarano JM; Banegas Banegas JR; Ortega Sánchez-Pinilla R; Gil Guillén V; Solana Saura P;
    Aten Primaria; 2007 Nov; 39 Suppl 3():15-26. PubMed ID: 19288694
    [No Abstract]   [Full Text] [Related]  

  • 3. Natural antioxidant compounds in risk factors for CVD.
    Kaliora AC; Dedoussis GV
    Pharmacol Res; 2007 Aug; 56(2):99-109. PubMed ID: 17572098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".
    Paraskevas KI
    J Vasc Surg; 2008 Sep; 48(3):776-7; author reply 777. PubMed ID: 18727983
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of hypertension and dyslipidemia in diabetes mellitus.
    Fineberg SE
    Prim Care; 1999 Dec; 26(4):951-64. PubMed ID: 10523469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Other antihyperuricemic agents].
    Ogino K; Igawa O; Hisatome I
    Nihon Rinsho; 2008 Apr; 66(4):754-7. PubMed ID: 18409527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of managing hypertension and dyslipidemia to decrease cardiovascular disease.
    Kostis JB
    Cardiovasc Drugs Ther; 2007 Aug; 21(4):297-309. PubMed ID: 17605096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence.
    Foody JM; Benner JS; Frishman W
    J Clin Hypertens (Greenwich); 2007 Apr; 9(4):271-5. PubMed ID: 17396070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost and effectiveness of adherence-improving interventions for antihypertensive and lipid-lowering drugs*.
    Chapman RH; Ferrufino CP; Kowal SL; Classi P; Roberts CS
    Int J Clin Pract; 2010 Jan; 64(2):169-81. PubMed ID: 20089007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixed drug combination in hypertension and hyperlipidaemia in the developing world.
    Seedat YK
    Cardiovasc J Afr; 2008; 19(3):124-6. PubMed ID: 18568170
    [No Abstract]   [Full Text] [Related]  

  • 11. Medications and cardiovascular health in older adults: room for improvement in prevention and treatment.
    Rhoads CS; Psaty BM; Olson JL; Furberg CD
    Am J Geriatr Cardiol; 2004; 13(3):161-7. PubMed ID: 15133419
    [No Abstract]   [Full Text] [Related]  

  • 12. [Eicosapentaenoic acid ethyl esters].
    Ohtsuka S
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():489-93. PubMed ID: 17824076
    [No Abstract]   [Full Text] [Related]  

  • 13. [Alpha adrenergic receptor blockers for patients with hypertension].
    Iwatsubo K; Umemura S
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():294-9. PubMed ID: 16981559
    [No Abstract]   [Full Text] [Related]  

  • 14. HOPE-‑3, BP treatment, milestones in CV prevention. Dr. Salim Yusuf in an interview with Dr. Akbar Panju and Dr. Roman Jaeschke.
    Yusuf S; Panju A; Jaeschke R
    Pol Arch Med Wewn; 2016 Dec; 126(12):1033-1035. PubMed ID: 28010010
    [No Abstract]   [Full Text] [Related]  

  • 15. New evidence in hypertension and hyperlipidaemia.
    Chapman N
    Heart; 2004 Jun; 90 Suppl 4(Suppl 4):iv14-7. PubMed ID: 15145906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy: ACCORD Blood Pressure and ACCORD Lipid: how low can we go?
    Glandt M; Raz I
    Nat Rev Endocrinol; 2010 Sep; 6(9):483-4. PubMed ID: 20720591
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment for hypertension with metabolic disorders (DM etc)].
    Shimamoto K; Miura T
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():513-9. PubMed ID: 16981585
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological treatment of lipid disorders in diabetes mellitus.
    Lopes-Virella MF; Colwell JA
    Diabetes Metab Rev; 1987 Jul; 3(3):691-722. PubMed ID: 3608755
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular risk in patients with renal disease: treating the risk or treating the risk factor?
    Rabelink TJ
    Nephrol Dial Transplant; 2004 Jan; 19(1):23-6. PubMed ID: 14671033
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapy and clinical trials.
    Curr Opin Lipidol; 1997 Dec; 8(6):B77-85. PubMed ID: 9412779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.